Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pain, Postoperative × Epinephrine × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pain, Postoperative 1 Oropharyngeal Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia 1 Hodgkin Disease 1 Carcinoma, Small Cell 1 Anus Neoplasms 1

Interventions

Bupivacaine 2 onabotulinum toxin A 1 Saline Solution 1 Morphine 1 Midazolam 1 Epinephrine 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03560362 2018-06-20

Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

University of Tennessee

Phase 1/2 Unknown

Lung Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡